US Patent Issued to Wyvern Pharmaceuticals on Sept. 16 for "Compositions and methods for regulating production of an antibody like protein and ribonucleic acid" (Canadian Inventor)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,850, issued on Sept. 16, was assigned to Wyvern Pharmaceuticals Inc. (Calgary, Canada).

"Compositions and methods for regulating production of an antibody like protein and ribonucleic acid" was invented by Bradley G. Thompson (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to one or more agents, therapies, treatments, and methods of use of the agents and/or therapies and/or treatments for producing an antibody like protein (ALP) and one or more sequences of miRNA that are complementary to the mRNA of a target, viral-specific protein or proteins. Embodiments of the present disclosure can be used as a th...